Cerebral Metabolic Stress Improves after Voxelotor Treatment in Pediatric Sickle Cell Disease

被引：1
|
作者：
Brothers, Rowan O. [1 ,2 ]
Turrentine, Katherine B. [1 ,2 ]
Akbar, Mariam [1 ,2 ]
Triplett, Sydney [1 ,2 ]
Urner, Tara M. [1 ,2 ]
Tang, Amy Y. [3 ,4 ]
Brown, Clark [3 ,5 ,6 ]
Buckley, Erin M. [1 ,2 ,3 ,6 ]
机构：
[1] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Aflac Canc & Blood Disorders Ctr Childrens Health, Atlanta, GA USA
[4] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[5] Global Blood Therapeut, San Francisco, CA USA
[6] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-169025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8296 / 8297
页数：2
相关论文
共 50 条
  • [1] Voxelotor for the treatment of sickle cell disease in pediatric patients
    Brown, Clark
    Tonda, Margaret
    Abboud, Miguel R.
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (06) : 485 - 492
  • [2] Changes in indicators of cerebral metabolic stress following treatment with voxelotor in children and adolescents with sickle cell anemia
    Heitzer, Andrew M.
    Zou, Ping
    Hodges, Jason
    Brown, Clark
    Davis, Mark
    Dixon, Sandy
    Ogg, Robert J.
    Estepp, Jeremie
    Hankins, Jane S.
    Sitaram, Ranganatha
    Takemoto, Clifford M.
    EJHAEM, 2024, 5 (05): : 976 - 980
  • [3] Voxelotor for the treatment of sickle cell disease
    Vissa, Madhav
    Vichinsky, Elliott
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 253 - 261
  • [4] The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease
    Brothers, Rowan O.
    Turrentine, Katherine B.
    Akbar, Mariam
    Triplett, Sydney
    Zhao, Hongting
    Urner, Tara M.
    Goldman-Yassen, Adam
    Jones, Richard A.
    Knight-Scott, Jack
    Milla, Sarah S.
    Bai, Shasha
    Tang, Amy
    Brown, R. Clark
    Buckley, Erin M.
    BLOOD, 2024, 143 (21) : 2145 - 2151
  • [5] Voxelotor: A Novel Treatment for Sickle Cell Disease
    Herity, Leah B.
    Vaughan, DaleMarie M.
    Rodriguez, Lindsey Ftitenour
    Lowe, Denise Kozella
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) : 240 - 245
  • [6] Voxelotor in sickle cell disease
    Bain, Barbara J.
    Myburgh, Jane
    Hann, Amanda
    Layton, D. Mark
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 830 - 832
  • [7] Acute venous thromboembolism after initiation of voxelotor for treatment of sickle cell disease
    Lemon, Natalie
    Sterk, Ethan
    Rech, Megan A.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 225.e1 - 225.e3
  • [8] Effect of voxelotor on cerebral perfusion and cerebral oxygen metabolism and cardiac stress in adult patients with sickle cell disease
    Konte, Kadere
    Afzali-Hashemi, Liza
    Baas, Koen P. A.
    Schrantee, Anouk
    Wood, John C.
    Nur, Erfan
    Nederveen, Aart J.
    Biemond, Bart J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (01) : 78 - 84
  • [9] Patient perception of voxelotor treatment benefit in sickle cell disease
    Idowu, Modupe
    Haque, Anam
    Williams, Elisa M.
    Sridhar, Arthi
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (05) : 1316 - 1319
  • [10] Voxelotor: A new kid on the block in the treatment of sickle cell disease
    Canak, Betul
    Eskazan, Ahmet Emre
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2564 - 2565
12345